OrthoPediatrics Corp. The company is headquartered in Warsaw, Indiana.
| Revenue (TTM) | $252.72M |
| Gross Profit (TTM) | $186.14M |
| EBITDA | -445,000 |
| Operating Margin | -5.77% |
| Return on Equity | -11.40% |
| Return on Assets | -2.81% |
| Revenue/Share (TTM) | $10.65 |
| Book Value | $13.16 |
| Price-to-Book | 1.70 |
| Price-to-Sales (TTM) | 2.34 |
| EV/Revenue | 2.523 |
| EV/EBITDA | 48.54 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 15.40% |
| Shares Outstanding | $26.11M |
| Float | $18.22M |
| % Insiders | 29.70% |
| % Institutions | 65.89% |
Volatility is currently expanding
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP).
Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology
OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript
WARSAW, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2026.
WARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, held in Boston, MA.
WARSAW, Ind., July 21, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2026 financial results on Tuesday, August 4, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 4, 2026 at 4:30 p.m. ET to discuss the results.
WARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with OSSIO, Inc. (“OSSIO”) that brings U.S. children's hospitals nationwide a bio-integrative, metal-free fixation technology ideally suited for treatment of fractures and deformities in pediatric patients.
OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
WARSAW, Ind., May 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Fred Hite, Chief Operating Officer, and Chief Financial Officer, is scheduled to participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference, held in Miami Beach, FL.
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on KIDS and any ticker you trade — then tracks every position and per-strategy win rate.
